

(Alliance News) - Sareum Holdings PLC on Friday said it has ended a study of its drug SDC-1801 after safety issues observed in animals involved in the...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.


(Sharecast News) - Clinical-stage biotechnology firm Sareum said on Friday that it has discontinued its 16-week pre-clinical toxicology study for auto...


(Alliance News) - Sareum Holdings PLC on Tuesday reported a strategic collaboration with AI-driven drug discovery firm, Receptor.AI, as it looks to ac...


(Sharecast News) - Sareum announced the start of a programme of toxicology studies on Thursday, for its lead TYK2/JAK1 inhibitor - SDC-1801 - marking ...


(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separate...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.


(Alliance News) - Sareum Holdings PLC on Tuesday said a biopharma company in the US has served notice to terminate a development & commercialisation l...